MedTrace Logo

Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.

NCT04186026 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2023-05-17

No results posted yet for this study

Summary

Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.

Conditions

Interventions

OTHER

Saline + saline

Double saline infusion followed by an ad libitum meal

OTHER

Neurotensin + saline

Neurotensin + saline infusion followed by an ad libitum meal

OTHER

GLP-1 + saline

GLP-1 + saline infusion followed by an ad libitum meal

OTHER

GLP-1 + Neurotensin

GLP-1 + Neurotensin infusion followed by an ad libitum meal

Sponsors & Collaborators

  • Copenhagen University Hospital, Hvidovre

    collaborator OTHER

  • University of Copenhagen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2024-06-10
Completion
2024-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04186026 on ClinicalTrials.gov